Article Text
Statistics from Altmetric.com
Since I became editor in late 2019, JIM has shown extraordinary growth across the board. I would like to take this opportunity to provide readers with a snapshot of JIM’s progress in 2020.
After a 3-year period of relatively little growth, submissions were up 78% in 2020 (figure 1), reaching an all-time high since transitioning to BMJ in 2016. Original research articles, reviews, and brief reports all increased by almost 70%. This growth is also reflected in an increase of published papers of approximately 40%, the result of the Editorial team’s continued focus on quality while also maintaining a stable acceptance rate of 30%.
Submissions and published papers, 2017–2020.
Over the past several years, JIM has benefited from a push for open access. 2020 was no …
Footnotes
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned; internally peer reviewed.